BRF1 Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q92994 |
---|---|
Clone Names | 100430343 |
Gene ID | 2972 |
---|---|
Other Names | Transcription factor IIIB 90 kDa subunit, TFIIIB90, hTFIIIB90, B-related factor 1, BRF-1, hBRF, TAF3B2, TATA box-binding protein-associated factor, RNA polymerase III, subunit 2, BRF1, BRF, GTF3B, TAF3B2, TAF3C |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | BRF1 |
---|---|
Synonyms | BRF, GTF3B, TAF3B2, TAF3C |
Function | General activator of RNA polymerase which utilizes different TFIIIB complexes at structurally distinct promoters. The isoform 1 is involved in the transcription of tRNA, adenovirus VA1, 7SL and 5S RNA. Isoform 2 is required for transcription of the U6 promoter. |
Cellular Location | Nucleus. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes one of the three subunits of the RNApolymerase III transcription factor complex. This complex plays acentral role in transcription initiation by RNA polymerase III ongenes encoding tRNA, 5S rRNA, and other small structural RNAs. Thegene product belongs to the TF2B family. Two alternatively splicedvariants encoding different isoforms, that function at differentpromoters transcribed by RNA polymerase III, have been identified.Other transcript variants are possible, but their full-lengthnatures have not been completely characterized. [provided byRefSeq].
References
Haurie, V., et al. Proc. Natl. Acad. Sci. U.S.A. 107(9):4176-4181(2010)Maitra, S., et al. RNA 14(5):950-959(2008)Leal, J.F., et al. Oncogene 27(14):1961-1970(2008)Yoo, N.K., et al. Cell. Microbiol. 10(3):583-592(2008)Cabarcas, S., et al. BMC Mol. Biol. 9, 74 (2008) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.